Showing 1 - 10 of 1,512
I investigate the contribution of pharmaceutical innovation to recent longevity growth in Germany and France. First, I examine the effect of the vintage of prescription drugs (and other variables) on the life expectancy and age-adjusted mortality rates of residents of Germany, using...
Persistent link: https://www.econbiz.de/10003977959
I investigate the contribution of pharmaceutical innovation to recent longevity growth in Germany and France. First, I examine the effect of the vintage of prescription drugs (and other variables) on the life expectancy and age-adjusted mortality rates of residents of Germany, using...
Persistent link: https://www.econbiz.de/10013069689
Persistent link: https://www.econbiz.de/10012649390
We evaluate the impact of government mandated proof of vaccination requirements for access to public venues and non-essential businesses on COVID-19 vaccine uptake. We find that the announcement of a mandate is associated with a rapid and significant surge in new vaccinations (more than 60%...
Persistent link: https://www.econbiz.de/10012795392
Persistent link: https://www.econbiz.de/10012666764
Persistent link: https://www.econbiz.de/10012433647
Persistent link: https://www.econbiz.de/10014229927
Objectives: This note provides an assessment of COVID-19 acceleration among groups with different vaccine status in France.Methods: We assess viral acceleration using a novel indicator introduced in Baunez et al. (2021). The acceleration index relates the percentage change of tests that have...
Persistent link: https://www.econbiz.de/10013324430
Persistent link: https://www.econbiz.de/10003718171
Persistent link: https://www.econbiz.de/10003972551